The Impact of Comorbidities and Organ Dysfunction Commonly Used for Clinical Trial Eligibility Criteria on Outcome in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy

被引：1
|
作者：
Statler, Abby [1 ]
Hobbs, Brian P. [2 ]
Radivoyevitch, Tomas [3 ]
Siebenaller, Caitlin [4 ]
Mukherjee, Sudipto [5 ]
Advani, Anjali S. [5 ]
Gerds, Aaron T. [5 ]
Nazha, Aziz [5 ]
Patel, Bhumika J. [5 ]
Carraway, Hetty E. [5 ]
Sekeres, Mikkael A. [5 ]
机构：
[1] Cleveland Clin, Canc Biostat, Shaker Hts, OH USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA
[3] Quantitat Hlth Sci, Dept Quantitat Hlth Sci & Translat Hematol & Onco, Cleveland, OH USA
[4] Cleveland Clin Taussig Canc Inst, Leuekmia Program, Cleveland, OH USA
[5] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Leukemia Program, Cleveland, OH USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-130319
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?
    Statler, Abby
    Hobbs, Brian P.
    Radivoyevitch, Tomas
    Mukherjee, Sudipto
    Bell, Kimberly
    Advani, Anjali S.
    Gerds, Aaron T.
    Nazha, Aziz
    Patel, Bhumika J.
    Carraway, Hetty E.
    Sekeres, Mikkael A.
    BLOOD, 2019, 134
  • [2] Severity of and contributors to distress in patients with acute myeloid leukemia (AML) receiving induction chemotherapy
    LeBlanc, Thomas William
    Wolf, Steven Paul
    Davis, Debra M.
    Samsa, Greg
    Locke, Susan C.
    El-Jawahri, Areej
    Tulsky, James A.
    Abernethy, Amy P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [3] The prognostic role of serum albumin in patients receiving induction chemotherapy for acute myeloid leukemia (AML)
    Sadrzadeh, Hossein
    Brunner, Andrew Mark
    Drapkin, Benjamin Jacob
    Babirak, Loren
    Werner, Lillian
    Ballen, Karen K.
    Amrein, Philip C.
    Attar, Eyal C.
    Chen, Yi-Bin Albert
    Spitzer, Thomas R.
    McAfee, Steven L.
    Neuberg, Donna S.
    Fathi, Amir Tahmasb
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Changes in the Gut Microbial Diversity and Its Correlation with the Clinical Outcome in Children with Acute Myeloid Leukemia (AML) Receiving Induction Chemotherapy
    Adel, Mai
    Khedr, Reham Abdelaziz
    Elsayed, Ahmed
    Shalaby, Lobna
    Omar, Abdelrahman
    Diab, Aya A.
    Elanany, Mervat
    Lehmann, Leslie E.
    Elhaddad, Alaa
    BLOOD, 2022, 140 : 11769 - 11770
  • [5] Identifying eligibility criteria that perpetuate race/ethnic disparities in acute myeloid leukemia (AML) clinical trial participation
    Hantel, Andrew
    Wang, Yating
    Abraham, Ivy
    Patel, Anand Ashwin
    Monick, Sarah Elizabeth
    Rauscher, Garth H.
    Rodriguez, Ana Maria Avila
    Galvez, Carlos
    Doukas, Peter
    Altman, Jessica K.
    Burkart, Madelyn
    Erra, Amani
    Zia, Maryam
    Larson, Melissa L.
    Dave, Ami Atulkumar
    Tsai, Stephanie
    Aleem, Ahmed
    Raptis, Nepheli
    Khan, Irum
    Abel, Gregory A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Patterns of Undertreatment Among Patients with Acute Myeloid Leukemia (AML) Not Receiving Standard Intensive Induction Chemotherapy
    Hubscher, Elizabeth
    Sikirica, Slaven
    Bell, Timothy J.
    Brown, Andrew
    Welch, Verna L.
    Russell-Smith, Alexander
    D'Amico, Paul G.
    BLOOD, 2020, 136
  • [7] A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy
    Alibhai, Shabbir M. H.
    O'Neill, Sara
    Fisher-Schlombs, Karla
    Breunis, Henriette
    Brandwein, Joseph M.
    Timilshina, Narhari
    Tomlinson, George A.
    Klepin, Heidi D.
    Culos-Reed, S. Nicole
    LEUKEMIA RESEARCH, 2012, 36 (10) : 1255 - 1261
  • [8] Impact of comorbidities on the outcome of elderly patients with acute myeloid leukemia.
    Etienne, Anne
    Esterni, Benjamin
    Charbonnie, Aude
    Prebet, Thomas
    Coso, Diane
    Stoppa, Anne-Marie
    D'Incan, Evelyne
    Sainty, Danile
    Arnoulet, Christine
    Mozziconacci, Marie-Joelle
    Gastaut, Jean-Albert
    Vey, Norbert
    BLOOD, 2006, 108 (11) : 559A - 559A
  • [9] Impact of Insurance Status on the Day of Admission and Clinical Outcome on Acute Myeloid Leukemia (AML)Patients
    Ahmad, Bilal
    Maymani, Hossein
    Saeed, Haseeb
    Khawandanah, Mohamad
    Srour, Samer A.
    Machiorlatti, Michael G.
    Asch, Adam S.
    Cherry, Mohamad
    BLOOD, 2014, 124 (21)
  • [10] IMPACT OF INSURANCE STATUS ON THE DAY OF ADMISSION AND CLINICAL OUTCOME IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS
    Ahmad, B.
    Pierson, N.
    Maymani, H.
    Khawandanah, M.
    Srour, S.
    Asch, A.
    Cherry, M.
    Saeed, H.
    Machiorlatti, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (04) : 682 - 682
12345